VXRT - Vaxart's Technology Could Be A COVID-19 Game Changer
Vaxart (VXRT) has soared over 2,000% YTD amid an acceptance to the Russell 3000, joining Operation Warp Speed, and the possibility of an effective COVID-19 'tablet' vaccine. The COVID-19 hype in other small-cap, speculative vaccine players like Novavax (NVAX), Inovio (INO), and Sorrento Therapeutics (SRNE) has fueled similar strong rallies. Yet, Vaxart is producing a completely different style of vaccine technology, which could, if it shows efficacy and safety, could unlock a realm of possibilities for COVID-19 and with other viral infections as well.
Vaxart's technology surrounds orally deliverable